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ABSTRACT The properties of transmembrane and solu-
ble transplantation antigens were compared with respect to the 
induction of tolerance and the selection of the T -ceU repertoire. 
For this purpose, transgenic (H_26 x H-2")F1 mice were 
constructed that carry integrated copies of a modified H-2K" 
gene resulting in the secretion from various ceU types including 
thymocytes of soluble H-2K" molecules. Despite the presence of 
H-2Kk antigen, these mice were stiU able to generate an 
H-2Kk-specific T -ceU response. This response was comparable 
to that produced by nonnallittermates when stimulated with 
ceUs expressing membrane H-2Kk in a mixed Iymphocyte 
reaction. In contrast, only transgenic mice failed to generate a 
cytolytic T-ceU response to soluble H-2Kk antigen expressed by 
recombinant vaccinia virus and presented by the 8-21)1> mol-
ecule. These data imply the presence of two populations of 
aUoreactive cytolytic T ceUs. A smaU fraction of T ceUs 
recognizes aUoantigen as antigenic peptide(s) presented by 
other ouQor histocompatibility complex dass I molecules and 
toIerance can be induced in this popubltion by soluble aUoan-
tigen. Tbe ouQority of T ceUs, however, require the whole ceU 
membrane-expressed dass I molecule for recognition. This 
population is not afrected by toIerance induction to the soluble 
ouQor histocompatibility complex dass I molecule. 
In contrast to antibodies that can bind to soluble antigens 
such as free virus, receptors ofT lymphocytes only recognize 
foreign antigens that are associated with a major histocom-
patibility complex (MHC) moleeule on a cell membrane (1). 
This "MHC restricted antigen recognition" has become 
more understandable since the elucidation of the structure of 
a human MHC class I antigen, which has revealed a putative 
binding groove for antigen fragments (2). It is generally 
accepted that protein antigen (for instance, viral proteins) are 
processed by infected cells and presented to cytotoxic T 
lymphocytes (CTLs) by class I moleeules (3). In the case of 
alloreactive responses, such as transplant rejections, it is still 
unclear whether processing and presentation of class I pep-
tides by other class I moleeules is aprerequisite for recog-
nition by CTLs (4-7). If the number of alloreactive CTLs 
responding to a processed form of class I were a substantial 
fraction of the total number of CTLs reacting with class I 
antigen, this would have major implications for the induction 
of tolerance to class I antigens and on the modulations of 
transplant rejections. To study this question in more detail, 
we have recently designed a transgenie mouse model to test 
the influence of membrane-bound versus soluble alloantigen 
on the induction of tolerance and selection of the T-cell 
repertoire (8). 
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Transgenie (H-2b X H-2d )F1 mice were established carry-
ing integrated copies of a modified H-2Kk gene, which led to 
secretion of soluble H-2Kk antigen by various cell types 
including thymocytes. Soluble H-2Kk was present in the sera 
of the transgenie animals (200 nglml). In spite of this, the 
transgenie mice were able to generate H-2Kk-specific CTL 
responses when stimulated with cell membrane-bound H-2Kk 
antigens (8). We have now analyzed the CTL responses of 
these animals to soluble H-2Kk by using either cells or 
recombinant vaccinia virus expressing soluble H-2Kk for 
immunization. We show here that normal mice immunized in 
such a way can mount a CTL response specific for an H-2Kk 
fragment and restricted by H-2Db. However, transgenie mice 
expressing soluble H-2Kk are tolerant to MHC class I pre-
sented H-2Kk peptides. 
MATERIALS AND METHODS 
Construction of the Modified H-2K" cDNA. A complete 
H-2Kk cDNA was obtained by recombination oftwo mutant 
H-2Kk cDNA clones (9): a 920-base-pair (bp) Ava 11/ BamHI 
fragment ofpcDk-l contained the cDNA part 3' to the Ava 11 
site and a 300-bp Ava II/BamHI fragment of pcDk-6 con-
tained the cDNA part 5' to the Ava 11 site. These two 
fragments were cloned into the BamHI site of pUCI9. The 
H-2Kd cDNA, in contrast to H-2Kk, contains a HindIll site 
exactly 3' of the a3 domain coding region appropriate for the 
insertion of a stop codon. Hence, the PsI I/BamHI 3' 
fragment of the H-2Kk cDNA was replaced by the same 
fragment from an H-2Kk cDNA (obtained from P. Kourilsky, 
Paris). Insertion of a 22-bp stop codon into the HindIll site 
led to the modified H-2Kk cDNA C70. This was subsequently 
cloned into an expression vector containing the cytomega-
lovirus promoter and simian virus 40 poly(A) site (10). 
Construction of Recombinant Vaccinia Virus. The modified 
H-2Kk cDNA C70 was cloned into the BamHI site of the 
vaccinia virus recombinant vector CS43. To improve yield of 
plasmid DNA a 2.0-kbp HindIII/Xho I fragment of pGS62 
(11) containing the vaccinia virus thymidine kinase gene 
driven by the 7.5-kbp promoter was inserted by blunt-end 
ligation into vector pUC9 cut with EcoRI and HindIll result-
ing in a plasmid, pCS43. Construction of the recombinant 
vaccinia virus followed established procedures (12) using the 
vaccinia virus strain Copenhagen and its temperature-
sensitive mutant ts7 (13). Recombinant vaccinia virus con-
taining the modified H-2Kk cDNA was termed VacKkTM-. 
CeU Culture and Transfection of CeUs. The fibroblast cell 
lines 1T22-6 (H-2q) and 3T3 (H-2d) were used for DNA 
transfeetions. Cell culture conditions, DNA transfeetion, and 
Abbreviations: CTL, cytotoxic T lymphocyte; MHC, major histo-
compatibility complex; MLR, mixed lymphocyte reaction; IL-2, 
interleukin 2. 
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analysis of transfectants by immunoprecipitation with mono-
clonal antibodies and gel electrophoresis were performed as 
described (14). 
Generation of CTLs. Transgenic mice or nontransgenic 
littermates were immunized either with 5 x 107 transgenic 
spleen cells subcutaneously or with 5 x 107 plaque-forming 
units of recombinant vaccinia virus or wild-type virus Co-
penhagen intravenously. After 3-6 weeks, immune spleen 
cells (5 x lW cells per ml in 24-well culture plates) were 
restimulated for 5 days in vitra with spleen cells oftransgenic 
mice (2.5 x Hf cells per ml). The CTL population was 
expanded for another 3 days with 25 units per ml of recom-
binant interleukin 2 (lL-2). Alloreactive CTLs were gener-
ated in mixed Iymphocyte cultures as described (14). 
Target CeIIs and Cytolytic Assays. IC9 fibrosarcoma cells 
(15) were infected with 1 plaque-forming unit per cell of 
vaccinia virus strain Copenhagen. After 2 hr, the inoculum 
was removed, fresh medium was added, and cells were 
incubated ovemight (12-18 hr). Target cells were treated with 
trypsin, labeled for 90 mln with Na2Cr04, and used in a 4-hr 
standard chromium release assay (14). 
RESULTS 
Construction and Expression of the Modified H-2Kk cDNA. 
To test the putative antigenic ditTerence between transmem-
brane and soluble c1ass I protein, the appropriate cell trans-
fectants and a recombinant viral vector were prepared. The 
modified H-2Kk cDNA C70, which resulted in a secreted 
H-2Kk antigen, was constructed in two consecutive steps 
(Fig. U). First, a Pst 1/ BamHI fragment ofthe H-2Kk cDNA 
was replaced by the same fragment of an H-2Kd cDNA to 
introduce the HindIll restriction enzyme site exactly 3' ofthe 
region coding for the a3 domain. In the second step, this 
HindlII site was used to insert a stop codon. The resulting 
modified cDNA encodes the signal sequence and the three 
outer domains of the H-2Kk antigen. There are four amino 
acid ditTerences at the carboxyl-terminal end of the a3 
domain in comparison to the wild-type H-2Kk introduced by 
the H-2Kd cDNA. The construct, called C70, was then c10ned 
either into the expression vector pL31 containing the cy-
tomegalovirus promoter and the simian virus 40 poly(A) site 
in pUC19 (10) (pC70), or into the vaccinia virus recombina-
tion vector CS43. The recombinant plasmid CS43-C70 was 
used together with Copenhagen strain DNA to transfect CVl 
cells infected with the ts7 mutant strain of Copenhagen. The 
recombinant vaccinia virus VacKkTM- containing the mod-
ified H-2Kk cDNA was selected after a temperature shift 
from 33°C to 39.5°C in the presence of BrdUrd (13). 
The modified H-2Kk cDNA containing the stop codon 3' of 
the region coding for the a3 domain (pC70) was transfected 
into IT22-6 cells. The resulting transfectants were screened 
for expression of mRNA in a dot blot using an H-2Kk-specific 
oligonucleotide (16). Positive cell clones were characterized 
by immunoprecipitation with monoclonal anti-H-2Kk anti-
bodies and subsequent analysis by NaDodS04/PAGE. The 
antibody Hl00-27.55 (17) precipitated the C70 antigen from 
the celllysate as weil as from the cell supematant (Fig. IB, 
lanes 1 and 2). The antigen was found to be associated with 
ßl-microglobulin. The C70 antigen could also be precipitated 
with three other monoclonal antibodies, H-142-23, Hl00-5 
(17), and RI-9.6 (18) that have been shown to react with 
different epitopes on the H-2Kk molecule. Therefore, we 
conclude that the exchange of the four amino acids in the 
carboxyl-terminal end of the a3 domain did not lead to a 
detectable alteration in the H-2Kk antigen. However, the 
introduction of a stop codon into the HindIll site led to an 
H-2Kk antigen that lacked the transmembrane and cytoplas-
mic regions, resulting in secretion. 
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FIG. 1. Construction and expression of the modified H-2Kk 
cDNA C70. (A) The 340-bp PSI I (P)I BamHI (8) fragment of the 
H-2Kk CDNA was replaced by thehomologous fragmentofan H-2Kd 
cDNA. The HindIll (H) site . which is exactly 3' of the a3 domain 
codinf region. was used to insert a stop codon. (B) The modified 
H-2K cDNA C70 was cloned in the expression vector pL31 con-
taining the cytomegalovirus promoter region and the simian virus 40 
poly(A) site. The resulting plasmid pC70 was transfected into IT22-6 
fibroblasts. Transfectants were labeled with pSSjmethionine for 2 hr 
and were solubilized. Antigens in the ceillysate (Iane 1) and the cell 
supematant (lane 2) were precipitated with the monoclonal anti-
H-2Kk antibody H100-27.55 and analyzed by NaDodS04/PAGE. 
The C70 DNA was also cloned in a recombinant vaccinia virus vector 
and IT22-6 cells were infected with either the wild-type or the 
recombinant vaccinia virus for 36 hr. Labeling of cells and immu-
noprecipitation were done as described above. Lanes 3 and 4. Iysate 
and supematant material from wild-type infected cells; lanes 5 and 6, 
material from cells infected with VacKkTM-. In lanes 1 and 5, the 
C70 antigen migrates according to an apparent molecular weight 
(MW) of36.000 in association with ß2-microglobulin <ß2m). In the cell 
supematant of the transfectants (Iane 2), secreted C70 antigen 
exhibits an apparent molecular weight of 39,000. 
IT22-6 cells were infected with 10 plaque-forming units per 
cell of either wild-type vaccinia virus strain Copenhagen or 
with recombinant virus VacKkTM- for 1 hr. After an infec-
tion period of 36 hr, cells were labeled for 2 hr with 
[35S]methionine and were then solubilized. As shown in Fig. 
IB, the C70 antigen, associated with ß2-microglobulin, could 
be seen in Iysates of cells infected with recombinant virus 
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VacKkTm- after immunoprecipitation with the antibody 
H100-27.55 (Fig.IB, lane 5). Apparently, the C70antigen was 
not !Iecreted in sufficient amounts for detection in cell su-
pematant (lane 6). Asexpected,the C70 antigen was not 
detected in lysates and supernatants of cells infected with 
wild-type virus (lanes 3 and 4). 
Thus, infection of cells with the recombinant vaccinia virus 
leadsto an H-2Kk aritigen of the same size as the antigen 
obtained by traitsfection with the pC70 plasmid. The H-2Kk 
antigen coul<! not be seen on the cell surface of either 
transfected or infected cells by fluorescence-activated cell 
sorter analysis with the antibody H100-27.55 labeled with 
fluorescein isothiocyanate. 
hiduction of CTL Responses to Soluble H-2Kk Using Spleen 
CeUs of TransgeilicMice. Transgenic inice expressing the 
soluble H-2Kk gene product and their nontransgenic litter-
mates were tested for their ability to mount a CTL response 
to soluble H-2Kk antigen. Spleen cells of transgenic mice 
expressing soluble H-2Kk were used to immunize ilontrans-
genie littermates or transgenic mice by injecting 5 x 107 
spleen cells s.c. Three to six weeks later, spleen cells ofthe 
immunized animals were restimulated in vitro with irradiated 
spleen cells from transgenic mice. After 4 days, activated T 
cells were expanded for another 3 days with recombinant 
IL-2. These effector cells were tested on a panel of trans-
fectants as target cells. 3T3 fibroblasts were transfected with 
either the H-2Kb gene, the H~2Db (19) gene, pC70, pC70 plus 
H-2Kb, or pC70 plus H-2Db. Expression of the C70 antigen in 
the resulting transfectants was tested by mRNA amilysis arid 
immunopr~cipitation. Expression of the H-2Kb and H-2Db 
antigens was verified by fluorescence-activated cell sorter 
analysis with monoclonal antibodies (data not shown). As 
shown in Fig. 2A, the restimulated CTLs obtained from 
nontransgenic littermates could only lyse transfectarits· ex-
pressing both the H-2Db and the C70 antigens, whereas CTLs 
obtained from transgenic mice could not lyse any ofthe target 
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cells (Fig. 2B). Such effector cells, which apparently react 
with soluble H-2kk restricted by the H-2Db molecule, were 
not detectedin mixed lymphocyte reactions (MLRs) from 
nontransgenie mice stimulated in a primary response by 
either spleen cells oftransgenic mice expressing thesoluble 
H-2Kk (Fig. 2C) or by spleen cells of B10.BR (H_2Kk) mice 
(Fig. W) expressing membrane-bound H-2Kk. Target cells 
expressing the intact membrane-associated H-2Kk antigen 
without the H-2Db antigen were lysed by CTLs generated 
from both types of mice by stimulation with B10.BR spleen 
cells in vitro (Fig. 2 D and E). 
It has been shown that class I antigens can be processed by 
cells and that peptides of this antigen can be presented by 
other class I molecules (4). Therefore, the IC9 fibrosarcoma 
cellline, which expresses only H-2Db as a class I antigen (15), 
was trarisfected with the cOfllplete H-2Kk gene (15) to deter-
mine whether such cells could create the target structure for 
the CTL pOpulation reacting with the soluble H-2Kk in an 
H-2Db restricted fashion. This CTL population, which was 
obtained from nontransgenic littermates as described above, 
could indeed react with IC9 cells expressing the transfected 
H-2Kk antigen, butit could not lyse untransfected IC9 cells 
or IC9 expressing the H-2Kd antigen· (15) (Table 1). This 
result enabled us to localize the H-2Kk fragment that is 
associated with the H-2Db antigen. IC9 transfectants were 
used that expressed H~2Kk/H-2Kd hybrid antigeris (15). 
Target cells expressing only the eil domain of H-2Kk within 
the H~2Kcl molecule could be lysed by the CTL fopulation, 
whereas target cells expressing a2 and a3 ofH~2K within the 
H-2d molecule were not lysed. All the IC9 celllines used were 
equally susceptible to lysis by anti-H-2Db-specific CTLs 
(data not shown). 
hiduction of CTL Responses to Soluble H-2Kk Using the 
RecombinantVaccinia Virus. To confirm the results de-
scribed above, transgenic and nontransgenic mice were im-
munized with the recombinant vaccinia virus expressing 
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FIG. 2. CTL responses of C57BL/6 trans-
genie mice (TG) and nontrarisgenic Iittermates 
(nTG) against H-2Kk antigens. Mice were im-
munized with 5 x 107 spleen cells s.c. After 3-6 
weeks, spleen cells of tbe immuriized !lnimals 
were restimulated with irradiated spleen cells of 
transgenie mice for 4 days and activated T cells 
were expanded for another 3 days with recom-
binant IL-2. Effector populations from non-
transgenie (A) and transgenie (B) mice were 
tested on a panel of 3T3 transfectants as indi-
cated. CTLs obtained from primary MLRs were 
also tested: nontransgenie Iittermates anti-
transgenie mice (C), or anti-BI0.BR (H_2k) (D) 
mice, and transgenic mice anti-BIO.BR (E). 
Curves indicate resultsof the analysis of one 
representative mouse. Ten mice (A and B) or 
four mice (C-E) were analyzed. 
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Table 1. Localization of the H-2Kk fragment recognized by 
CTLs in association with H-2Db 


































Values indicate results ofthe analysis of one representative mouse. 
Eight mice were tested individuaIly. The percentages of lysis are 
mean values of triplicate wells analyzed. E/T, effectQr/target cell 
ratio. The IC9 fiblVsarcoma line expresses only H-2Db as a class I 
antigeri. CTLs were generated as described in the legend to Fig. 2. 
soluble H-2Kk. MHC class I molecules expressed by vaccinia 
virus vectors have been successfully applied for the gener-
ation of CTL responses to alloantigen (20). Irradiated spleen 
cells of transgenic animals were used for restimulation in 
vitro 3-6 weeks later. CTLs were expanded with recombi-
nant IL-2 as mentioned above. CTL populations isolated 
from nontransgenic Iittermates could Iyse IC9 cells express-
ing the H-2Kk antigen (Fig. 3A). CTL populations obtained 
from transgenic mice did not show this activity (Fig. 3B). The 
same results were obtained with the above-mentioned 3T3 
transfectaJits as targets (data not shown). On the other hand, 
if spleen cells from mice immunizedwith recombinant vac-
cinia virus VacKkTM- were tested 6-8 days after priming for 
their ability to Iyse wild-type vaccinia virus-infected target 
cells, no difference could be observed in the degree of 
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specific lysis by transgenic and nontransgenic animals (Fig. 
3 C and D). We can, therefore, conclude that nontransgenic 
Iittermates can res pond to recombinant vaccinia virus in 
activating CTLs specific for an H -2K k fragment in association 
with H-2Db. Transgenic mice, however, are tolerant to this 
target structure. Evidence for effective immunization of both 
types of mice was demonstrated by the primary in vivo 
anti-vaccinia virus response. 
DISCUSSION 
We have recently reported that transgenic mice expressing a 
foreign class I antigen in soluble form could still react with the 
same high frequency of CTL precursors to the membrane-
bound alloantigen as normal mice (8). We could, however, 
not exclude that the lack of tolerance toward the membrane 
antigen was based on the fact that the concentration of the 
antigenic protein in the serum (200 ng/m1) might have been 
insufficient to induce any tolerance. We have therefote 
extended the analysis of these transgenic mice to study their 
reactivity to the soluble form of the class I antigen. H-
2Kk-specific, H-2Db-restricted CTLs were induced in non-
transgenic Iittermates by immunization with either spleen 
cell~ of transgenic mice or by recombinant vaccinia virus 
expressing a soluble form of the H-2Kk antigen. A peptide 
fragment of the a1 domain of H-2Kk is recognized in asso-
ciation with H-2Db but not with H-2Kb under these condi-
tions. The observed specific cytolytic activity is smaller than 
the one resuIting from a primary anti-H-2Kk MLR and 
requires both in vivo priming and re stimulation in vitro. 
Our results confirm that normal mice can respond in two 
ways to MHC class I antigens: CTLs can be· generated 
B 
o 
• • • ----._--..--. 
FIG. 3. Generation of CTLs by immunization 
with recombinant vaccinia virus VacK~M-. Mice 
were immunized with 5 x 107 plaque-forming units 
ofvirus VacK~M- i.v. and were killed either after 
6-8 days for a primary anti-vaccinia virus response 
or after 3-6 weeks for the analysis of an anti-H-2Kk 
response. In the second case, spleen cells were 
restimulated with irradiated spleen cells from trans-
genie mice for 4 days. CTLs were expanded for 
another 3 days with recombinant IL-2. CTLs of 
nontransgenic (nTG) (A) or transgenie (TG) (B) 
mice were tested on IC9 (e) and 9Kk_34 (_) target 
cells. For the primary anti-vaccinia virus response, 
spleen cells ofnTG (C) and TG (D) were tested on 
either IC9 (e) or on infected IC9 target cells. 
Targets were infected with 10 plaque-forming units 
of vaccinia virus per cell for 1 hr and after removal 
of the inoculum were incubated ovemight (.). 
Curves indicate the result of the analysis of one 
representative mouse. Twelve mice of each type (A 
and B) or five mice of each type (C and D) were 
tested individually. 
100 25 100 25 
EFFEGTOR: TARGET GELL RATIO 
1766 Immunology: Arnold et al. 
reacting either with an intact class I antigen (H-2Kk) most 
likely associated with self peptides (21) or to a peptide 
fragment ofthis class I antigen (H-2Kk) in association with a 
membrane-bound class I antigen, such as H-2Db (4-7). The 
mice transgenie for the soiuble H-2Kk are still reactive 
toward the membrane-bound H-2Kk but they are clearly 
tolerant for H-2Kk peptide(s). 
These findings have three major implications. First, solu-
ble class I antigens cannot induce tolerance by direct binding 
to the receptors of T cells reactive with the intact form of the 
membrane-associated antigen. It has been shown that soluble 
class I antigen could interfere with the stimulation of an 
a1loreactive T-cell hybridoma in vitro (22). This T-cell hy-
bridoma was reactive to the membrane-bound H-2Kb antigen 
independent of selfMHC proteins. However, soluble H-2Kb 
moleeules could only inhibit stimulation ofthe T-cell hybrid-
oma under suboptimal conditions using H_2Kbm mutant an-
tigens. Therefore, these data do not contradict our in vivo 
results. 
Second, MHC moleeules can appear in two distinct anti-
genie structures. They can either present peptides them-
selves or they can be processed and presented in peptide form 
by self MHC molecules. CTLs generated in a primary MLR 
can Iyse transfectants expressing the relevant class I antigen 
irrespective of the haplotype of the transfected celliine (14, 
19). Thus, the intact class I antigen is essential for recogni-
tion. On the other hand, CTLs that react with class I peptides 
associated with self class I moleeules have been described in 
several systems (4-7). However, the percentage of these T 
cells must be low within the a1loreactive CTL precursor 
population, because no CTLs could be found specific for 
soluble H-2Kk in association with H-2Db in primary anti-
BI0.BR bulk cultures. Only bl immunization with transfec-
tants expressing soluble H-2K or with recombinant vaccinia 
virus could this H-2Kk-specific H-2Db-restricted response be 
obtained. The transgenie mice are tolerant for this type of 
T -cell specificity but can nevertheless res pond with a high 
CTL precursor frequency in a primary anti-H-2Kk MLR that 
is indistinguishable from normal mice (8). 
Third, an additional aspect of this work is related to the 
finding that tissue-specific, nonthymic expressed class I 
antigens in transgenie mice can lead to tolerance to this class 
I protein (23, 24). In the two systems that have currently been 
described, usage of an insulin promoter resulted in expres-
sion of H-2Kb in the pancreas (23), while a metallothionein 
promoter caused expression in the liver (24). However, it has 
been suggested that the observed tolerance could still be 
based on a thymic event. Class I antigens could be shedded 
from the respective tissue, taken up by cells migrating to the 
thymus, and presented by self class land 11 molecules. Our 
results contradict this suggestion. Even if peptides of the 
class I antigens that are expressed extrathymically could be 
presented in the thymus, only the small fraction of the 
a1loreactive CTL precursor pool that is specific for a class I 
peptide could be made tolerant. The majority of a1loreactive 
CTL precursors reacting with the intact class I antigen 
Proc. Natl. Acad. Sei. USA 87 (1990) 
should, however, be unaffected unless extrathymic tolerance 
mechanisms function. 
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